Cargando…

Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement System

The classical pathway of complement is important for protection against pathogens and in maintaining tissue homeostasis, but excessive or aberrant activation is directly linked to numerous pathologies. We describe the development and in vitro characterization of C1qNb75, a single domain antibody (na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laursen, Nick S., Pedersen, Dennis V., Gytz, Heidi, Zarantonello, Alessandra, Bernth Jensen, Jens Magnus, Hansen, Annette G., Thiel, Steffen, Andersen, Gregers R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396675/ https://www.ncbi.nlm.nih.gov/pubmed/32849513 http://dx.doi.org/10.3389/fimmu.2020.01504

Ejemplares similares

Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies
por: Zarantonello, Alessandra, et al.
Publicado: (2021)

Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor Activity
por: Pedersen, Henrik, et al.
Publicado: (2022)

Nanobody‐mediated complement activation to kill HIV‐infected cells
por: Pedersen, Maria Lange, et al.
Publicado: (2023)

Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System
por: Pedersen, Dennis V., et al.
Publicado: (2019)

Novel homozygous CD46 variant with C‐isoform expression affects C3b inactivation in atypical hemolytic uremic syndrome
por: Schack, Vivien R., et al.
Publicado: (2022)

Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
por: Gregersen, Emil, et al.
Publicado: (2021)

Low levels of the innate immune system proteins MASP‐2 and MAp44 in patients with common variable immunodeficiency
por: Mistegaard, Clara Elbæk, et al.
Publicado: (2022)

Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans
por: Halkjær, Lene, et al.
Publicado: (2020)

A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein
por: Yatime, Laure, et al.
Publicado: (2018)

Structural insights into the function-modulating effects of nanobody binding to the integrin receptor α(M)β(2)
por: Jensen, Rasmus K., et al.
Publicado: (2022)

Polysaccharide Responsiveness Is Not Biased by Prior Pneumococcal-Conjugate Vaccination
por: Bernth-Jensen, Jens Magnus, et al.
Publicado: (2013)

Introducing site-specific cysteines into nanobodies for mercury labelling allows de novo phasing of their crystal structures
por: Hansen, Simon Boje, et al.
Publicado: (2017)

Real-Time Relative qPCR without Reference to Control Samples and Estimation of Run-Specific PCR Parameters from Run-Internal Mini-Standard Curves
por: Bernth Jensen, Jens Magnus, et al.
Publicado: (2010)

The genetic component of preeclampsia: A whole-exome sequencing study
por: Hansen, Anette Tarp, et al.
Publicado: (2018)

Abundant human anti-Galα3Gal antibodies display broad pathogen reactivity
por: Bernth Jensen, Jens Magnus, et al.
Publicado: (2020)

Polymorphisms in the MASP1 Gene Are Associated with Serum Levels of MASP-1, MASP-3, and MAp44
por: Gytz Ammitzbøll, Christian, et al.
Publicado: (2013)

Trichinella spiralis Paramyosin Binds Human Complement C1q and Inhibits Classical Complement Activation
por: Sun, Ran, et al.
Publicado: (2015)

The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus
por: Troldborg, Anne, et al.
Publicado: (2018)

Editorial: State-of-the-Art Research on C1q and the Classical Complement Pathway
por: Kishore, Uday, et al.
Publicado: (2016)

Structure and function of a family of tick-derived complement inhibitors targeting properdin
por: Braunger, Katharina, et al.
Publicado: (2022)

Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults
por: LaFon, David C., et al.
Publicado: (2020)

Non-Synonymous Polymorphisms in the FCN1 Gene Determine Ligand-Binding Ability and Serum Levels of M-Ficolin
por: Ammitzbøll, Christian Gytz, et al.
Publicado: (2012)

Correction to: Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults
por: LaFon, David C., et al.
Publicado: (2021)

Floridoside Extracted from the Red Alga Mastocarpus stellatus Is a Potent Activator of the Classical Complement Pathway
por: Courtois, Anthony, et al.
Publicado: (2008)

Factors involved in initiation and regulation of complement lectin pathway influence postoperative outcome after pediatric cardiac surgery involving cardiopulmonary bypass
por: Michalski, Mateusz, et al.
Publicado: (2019)

Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement
por: Zhang, Jie, et al.
Publicado: (2020)

ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
por: Pihl, Rasmus, et al.
Publicado: (2021)

Diagnostic Vaccination in Clinical Practice
por: Hansen, Anette Tarp, et al.
Publicado: (2021)

C3‐dependent effector functions of complement
por: Zarantonello, Alessandra, et al.
Publicado: (2022)

Enzymatically Modified Low-Density Lipoprotein Is Recognized by C1q and Activates the Classical Complement Pathway
por: Arlaud, Gérard J., et al.
Publicado: (2011)

C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration
por: Yednock, Ted, et al.
Publicado: (2022)

Antibody-independent complement activation by myelin via the classical complement pathway
Publicado: (1982)

Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome
por: Sasaki, Shoh, et al.
Publicado: (2022)

Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration
por: Jiao, Haihan, et al.
Publicado: (2018)

Competitive inhibition of the classical complement pathway using exogenous single-chain C1q recognition proteins
por: Vadászi, Henrietta, et al.
Publicado: (2022)

Structural Investigations of Human A2M Identify a Hollow Native Conformation That Underlies Its Distinctive Protease-Trapping Mechanism
por: Harwood, Seandean Lykke, et al.
Publicado: (2021)

Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond
por: Pedersen, Dennis Vestergaard, et al.
Publicado: (2022)

The results of pancreatic surgery in Inuit patients from Greenland 1999-2022
por: Almdal, Kerstin, et al.
Publicado: (2023)

Identification of Novel Genetic Variants in CVID Patients With Autoimmunity, Autoinflammation, or Malignancy
por: Christiansen, Mette, et al.
Publicado: (2020)

Evidence for classic complement activity in neuromyelitis optica
por: Jones, Melina V., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jr8dpsgvppsl3t4hu4s550ndbg